obeticholic acid
Selected indexed studies
- Obeticholic Acid. (, 2012) [PMID:31644113]
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. (Lancet, 2019) [PMID:31813633]
- Obeticholic Acid for Primary Biliary Cholangitis. (Biomedicines, 2022) [PMID:36289726]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Obeticholic Acid. (2012) pubmed
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. (2019) pubmed
- Obeticholic Acid for Primary Biliary Cholangitis. (2022) pubmed
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. (2016) pubmed
- FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid. (2024) pubmed
- Obeticholic acid-a new therapy in PBC and NASH. (2020) pubmed
- Obeticholic acid for primary biliary cholangitis. (2020) pubmed
- Obeticholic Acid. (2026) pubmed
- Obeticholic acid for the treatment of nonalcoholic steatohepatitis. (2020) pubmed
- Obeticholic Acid: First Global Approval. (2016) pubmed